Radiofrequency ablation for intraductal extension of ampullary neoplasms

Tarun Rustagi, Shayan Irani, D. Nageshwar Reddy, Barham K. Abu Dayyeh, Todd H. Baron, Christopher J. Gostout, Michael J. Levy, John Martin, Bret Thomas Petersen, Andrew Ross, Mark Topazian

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background and Aims: Extension of ampullary adenomas into the common bile duct (CBD) or pancreatic duct (PD) may be difficult to treat endoscopically. We evaluated the feasibility, safety, and efficacy of endoscopic radiofrequency ablation (RFA) in the management of ampullary neoplasms with intraductal extension. Methods: This was a multicenter, retrospective analysis of all patients with intraductal extension of ampullary neoplasms treated with endoscopic RFA between February 2012 and June 2015. Treatment success was defined as the absence of detectable intraductal polyps by ductography, visual inspection, and biopsy sampling. Results: Fourteen patients with adenoma extension into the CBD (13 ± 7 mm, n = 14) and PD (7 ± 2 mm, n = 3) underwent a median of 1 RFA sessions (range, 1-5). Additional modalities (thermal probes, argon plasma coagulation, and/or photodynamic therapy) were also used in 7 patients, and prophylactic stents were routinely placed. Thirteen assessable patients underwent a median of 2 surveillance ERCPs after completion of treatment over a median follow-up of 16 months (range, 5-46), with intraductal biopsy specimens showing no neoplasm in 12 patients at the conclusion of endoscopic treatment. Treatment success was achieved in 92%, including 100% of those treated with RFA alone. Adverse events occurred in 43% and included ductal strictures (5 patients) and retroduodenal abscess (1 patient), all of which were successfully treated endoscopically. Conclusions: Endoscopic RFA, alone or in combination with other modalities, may effectively treat intraductal extension of ampullary neoplasms. Ductal strictures were common after RFA but responded to endoscopic stent therapy. RFA may be appropriate in selected patients, particularly when the main treatment alternative is pancreaticoduodenectomy.

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
DOIs
StateAccepted/In press - May 26 2016

Fingerprint

Neoplasms
Pancreatic Ducts
Common Bile Duct
Adenoma
Stents
Pathologic Constriction
Therapeutics
Argon Plasma Coagulation
Biopsy
Pancreaticoduodenectomy
Endoscopic Retrograde Cholangiopancreatography
Photochemotherapy
Polyps
Abscess
Hot Temperature
Safety

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Rustagi, T., Irani, S., Reddy, D. N., Abu Dayyeh, B. K., Baron, T. H., Gostout, C. J., ... Topazian, M. (Accepted/In press). Radiofrequency ablation for intraductal extension of ampullary neoplasms. Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2016.11.002

Radiofrequency ablation for intraductal extension of ampullary neoplasms. / Rustagi, Tarun; Irani, Shayan; Reddy, D. Nageshwar; Abu Dayyeh, Barham K.; Baron, Todd H.; Gostout, Christopher J.; Levy, Michael J.; Martin, John; Petersen, Bret Thomas; Ross, Andrew; Topazian, Mark.

In: Gastrointestinal Endoscopy, 26.05.2016.

Research output: Contribution to journalArticle

Rustagi, T, Irani, S, Reddy, DN, Abu Dayyeh, BK, Baron, TH, Gostout, CJ, Levy, MJ, Martin, J, Petersen, BT, Ross, A & Topazian, M 2016, 'Radiofrequency ablation for intraductal extension of ampullary neoplasms', Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2016.11.002
Rustagi, Tarun ; Irani, Shayan ; Reddy, D. Nageshwar ; Abu Dayyeh, Barham K. ; Baron, Todd H. ; Gostout, Christopher J. ; Levy, Michael J. ; Martin, John ; Petersen, Bret Thomas ; Ross, Andrew ; Topazian, Mark. / Radiofrequency ablation for intraductal extension of ampullary neoplasms. In: Gastrointestinal Endoscopy. 2016.
@article{1fffb74d1a024058bfd74a4e9dd00a9b,
title = "Radiofrequency ablation for intraductal extension of ampullary neoplasms",
abstract = "Background and Aims: Extension of ampullary adenomas into the common bile duct (CBD) or pancreatic duct (PD) may be difficult to treat endoscopically. We evaluated the feasibility, safety, and efficacy of endoscopic radiofrequency ablation (RFA) in the management of ampullary neoplasms with intraductal extension. Methods: This was a multicenter, retrospective analysis of all patients with intraductal extension of ampullary neoplasms treated with endoscopic RFA between February 2012 and June 2015. Treatment success was defined as the absence of detectable intraductal polyps by ductography, visual inspection, and biopsy sampling. Results: Fourteen patients with adenoma extension into the CBD (13 ± 7 mm, n = 14) and PD (7 ± 2 mm, n = 3) underwent a median of 1 RFA sessions (range, 1-5). Additional modalities (thermal probes, argon plasma coagulation, and/or photodynamic therapy) were also used in 7 patients, and prophylactic stents were routinely placed. Thirteen assessable patients underwent a median of 2 surveillance ERCPs after completion of treatment over a median follow-up of 16 months (range, 5-46), with intraductal biopsy specimens showing no neoplasm in 12 patients at the conclusion of endoscopic treatment. Treatment success was achieved in 92{\%}, including 100{\%} of those treated with RFA alone. Adverse events occurred in 43{\%} and included ductal strictures (5 patients) and retroduodenal abscess (1 patient), all of which were successfully treated endoscopically. Conclusions: Endoscopic RFA, alone or in combination with other modalities, may effectively treat intraductal extension of ampullary neoplasms. Ductal strictures were common after RFA but responded to endoscopic stent therapy. RFA may be appropriate in selected patients, particularly when the main treatment alternative is pancreaticoduodenectomy.",
author = "Tarun Rustagi and Shayan Irani and Reddy, {D. Nageshwar} and {Abu Dayyeh}, {Barham K.} and Baron, {Todd H.} and Gostout, {Christopher J.} and Levy, {Michael J.} and John Martin and Petersen, {Bret Thomas} and Andrew Ross and Mark Topazian",
year = "2016",
month = "5",
day = "26",
doi = "10.1016/j.gie.2016.11.002",
language = "English (US)",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Radiofrequency ablation for intraductal extension of ampullary neoplasms

AU - Rustagi, Tarun

AU - Irani, Shayan

AU - Reddy, D. Nageshwar

AU - Abu Dayyeh, Barham K.

AU - Baron, Todd H.

AU - Gostout, Christopher J.

AU - Levy, Michael J.

AU - Martin, John

AU - Petersen, Bret Thomas

AU - Ross, Andrew

AU - Topazian, Mark

PY - 2016/5/26

Y1 - 2016/5/26

N2 - Background and Aims: Extension of ampullary adenomas into the common bile duct (CBD) or pancreatic duct (PD) may be difficult to treat endoscopically. We evaluated the feasibility, safety, and efficacy of endoscopic radiofrequency ablation (RFA) in the management of ampullary neoplasms with intraductal extension. Methods: This was a multicenter, retrospective analysis of all patients with intraductal extension of ampullary neoplasms treated with endoscopic RFA between February 2012 and June 2015. Treatment success was defined as the absence of detectable intraductal polyps by ductography, visual inspection, and biopsy sampling. Results: Fourteen patients with adenoma extension into the CBD (13 ± 7 mm, n = 14) and PD (7 ± 2 mm, n = 3) underwent a median of 1 RFA sessions (range, 1-5). Additional modalities (thermal probes, argon plasma coagulation, and/or photodynamic therapy) were also used in 7 patients, and prophylactic stents were routinely placed. Thirteen assessable patients underwent a median of 2 surveillance ERCPs after completion of treatment over a median follow-up of 16 months (range, 5-46), with intraductal biopsy specimens showing no neoplasm in 12 patients at the conclusion of endoscopic treatment. Treatment success was achieved in 92%, including 100% of those treated with RFA alone. Adverse events occurred in 43% and included ductal strictures (5 patients) and retroduodenal abscess (1 patient), all of which were successfully treated endoscopically. Conclusions: Endoscopic RFA, alone or in combination with other modalities, may effectively treat intraductal extension of ampullary neoplasms. Ductal strictures were common after RFA but responded to endoscopic stent therapy. RFA may be appropriate in selected patients, particularly when the main treatment alternative is pancreaticoduodenectomy.

AB - Background and Aims: Extension of ampullary adenomas into the common bile duct (CBD) or pancreatic duct (PD) may be difficult to treat endoscopically. We evaluated the feasibility, safety, and efficacy of endoscopic radiofrequency ablation (RFA) in the management of ampullary neoplasms with intraductal extension. Methods: This was a multicenter, retrospective analysis of all patients with intraductal extension of ampullary neoplasms treated with endoscopic RFA between February 2012 and June 2015. Treatment success was defined as the absence of detectable intraductal polyps by ductography, visual inspection, and biopsy sampling. Results: Fourteen patients with adenoma extension into the CBD (13 ± 7 mm, n = 14) and PD (7 ± 2 mm, n = 3) underwent a median of 1 RFA sessions (range, 1-5). Additional modalities (thermal probes, argon plasma coagulation, and/or photodynamic therapy) were also used in 7 patients, and prophylactic stents were routinely placed. Thirteen assessable patients underwent a median of 2 surveillance ERCPs after completion of treatment over a median follow-up of 16 months (range, 5-46), with intraductal biopsy specimens showing no neoplasm in 12 patients at the conclusion of endoscopic treatment. Treatment success was achieved in 92%, including 100% of those treated with RFA alone. Adverse events occurred in 43% and included ductal strictures (5 patients) and retroduodenal abscess (1 patient), all of which were successfully treated endoscopically. Conclusions: Endoscopic RFA, alone or in combination with other modalities, may effectively treat intraductal extension of ampullary neoplasms. Ductal strictures were common after RFA but responded to endoscopic stent therapy. RFA may be appropriate in selected patients, particularly when the main treatment alternative is pancreaticoduodenectomy.

UR - http://www.scopus.com/inward/record.url?scp=85008210270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008210270&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2016.11.002

DO - 10.1016/j.gie.2016.11.002

M3 - Article

C2 - 27866907

AN - SCOPUS:85008210270

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

ER -